MyFinsight
Home
Blog
About
628fe2259e1c5d448ba8cd54_mpt_logo_2020rev_RGB-1-svg
MEDICAL PROPERTIES TRUST INC (MPW)
628fe2259e1c5d448ba8cd54_mpt_logo_2020rev_RGB-1-svg
MEDICAL PROPERTIES TRUST INC (MPW)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$111,022K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Real estate and other impairment...
Depreciation and amortization
Net proceeds from sale of real e...
Others
Negative Cash Flow Breakdown
Investment in loans receivable
Net loss
Dividends / distribution paid
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Net loss
-77,450
-98,068
-118,016
-412,322
Depreciation and amortization
69,476
68,238
65,431
66,204
Amortization of deferred financing costs and debt discount
6,862
6,706
5,796
5,082
Straight-line rent revenue and other
-
-
-
45,439
Straight-line rent revenue from operating and finance leases
37,916
41,157
41,601
-
Stock / unit-based compensation expense
12,342
857
17,665
2,395
Gain on sale of real estate
-9,115
5,212
8,059
3,497
Real estate and other impairment charges, net
85,653
1,898
79,581
386,973
Equity interest real estate impairment
0
0
-
0
Straight-line rent and other write-off
-
-
-
-332
Debt refinancing and unutilized financing (benefit) costs
-
-
-
4,292
Debt refinancing and unutilized financing costs
14
-181
119
-
Tax rate changes and other
-12,091
19
1,102
523
Non-cash fair value adjustments
-12,066
108,827
26,609
52,194
Other adjustments
4,409
7,788
-2,473
7,431
Interest and rent receivables
-3,740
2,061
-6,626
1,369
Other assets
-10,057
1,509
1,792
17,225
Accounts payable and accrued expenses
-33,841
23,522
-35,400
44,350
Deferred revenue
-914
-2,344
-3,827
5,966
Net cash provided by operating activities
18,572
51,747
384
76,687
Cash paid for acquisitions and other related investments
7,760
63,015
39,314
0
Net proceeds from sale of real estate
49,043
28,081
19,837
92,416
Proceeds received from sale and repayment of loans receivable
7,049
3,000
0
214,416
Investment in loans receivable
106,539
30,635
21,800
28,083
Construction in progress and other
20,124
14,570
26,053
16,253
Proceeds from sale and return of equity investments
0
0
0
0
Capital additions and other investments, net
16,804
-4,821
22,086
-43,657
Net cash (used for) provided by investing activities
-95,135
-72,318
-89,416
91,737
Proceeds from term debt
0
0
2,512,970
0
Payments of term debt
0
0
2,252,731
38,841
Revolving credit facility, net
15,000
-101,903
258,433
-12,000
Dividends / distribution paid
48,292
48,384
48,164
48,171
Lease deposits and other obligations to tenants
-505
1,273
-3,243
-2,963
Offering costs
543
101
-
-
Stock / unit vesting - satisfaction of tax withholdings
733
456
289
553
Other financing activities, payment of debt refinancing and deferred financing costs
-
-
-
-3,203
Payment of debt refinancing and deferred financing costs and other financing activities
396
2,680
47,142
-
Net cash provided by (used for) financing activities
-34,459
-154,797
426,320
-99,805
Increase in cash, cash equivalents, and restricted cash for period
-111,022
-175,368
337,288
68,619
Effect of exchange rate changes on cash
-2,253
11,791
4,024
-13,193
Cash and cash equivalents at beginning of period
676,485
676,485
335,173
230,218
Cash and cash equivalents at end of period
399,633
512,908
676,485
335,173
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Real estate and other
impairment charges, net
$85,653K
(-85.91%↓ Y/Y)
Depreciation and
amortization
$69,476K
(-66.35%↓ Y/Y)
Stock / unit-based
compensation expense
$12,342K
(-14.45%↓ Y/Y)
Other assets
-$10,057K
(-5.52%↓ Y/Y)
Gain on sale of real
estate
-$9,115K
(-109.93%↓ Y/Y)
Amortization of deferred
financing costs and debt...
$6,862K
(43.65%↑ Y/Y)
Interest and rent
receivables
-$3,740K
(11.40%↑ Y/Y)
Debt refinancing and
unutilized financing costs
$14K
(-99.62%↓ Y/Y)
Net cash provided by
operating activities
$18,572K
(-68.63%↓ Y/Y)
Canceled cashflow
$178,687K
Increase in cash, cash
equivalents, and restricted...
-$111,022K
(67.84%↑ Y/Y)
Canceled cashflow
$18,572K
Net proceeds from
sale of real estate
$49,043K
(-80.25%↓ Y/Y)
Proceeds received from
sale and repayment of...
$7,049K
(-92.95%↓ Y/Y)
Revolving credit
facility, net
$15,000K
(104.89%↑ Y/Y)
Lease deposits and
other obligations to...
-$505K
(-105.47%↓ Y/Y)
Net loss
-$77,450K
(90.33%↑ Y/Y)
Straight-line rent revenue
from operating and...
$37,916K
Accounts payable and
accrued expenses
-$33,841K
(-352.68%↓ Y/Y)
Tax rate changes and
other
-$12,091K
(-151237.50%↓ Y/Y)
Non-cash fair value
adjustments
-$12,066K
(-109.21%↓ Y/Y)
Other adjustments
$4,409K
(344.67%↑ Y/Y)
Deferred revenue
-$914K
(37.53%↑ Y/Y)
Net cash (used for)
provided by investing...
-$95,135K
(-166.18%↓ Y/Y)
Net cash provided by
(used for) financing...
-$34,459K
(93.71%↑ Y/Y)
Canceled cashflow
$56,092K
Canceled cashflow
$15,505K
Investment in loans
receivable
$106,539K
(39.74%↑ Y/Y)
Dividends / distribution
paid
$48,292K
(-46.54%↓ Y/Y)
Construction in progress and
other
$20,124K
(9.05%↑ Y/Y)
Capital additions and
other investments,...
$16,804K
(-84.70%↓ Y/Y)
Cash paid for
acquisitions and other...
$7,760K
Stock / unit vesting -
satisfaction of tax...
$733K
(74.94%↑ Y/Y)
Offering costs
$543K
Payment of debt
refinancing and deferred...
$396K
Buy us a coffee